In France Bluestar Silicones inaugurated its new resin manufacturing unit in its Saint Fons factory. The new production unit, named IRIS, will enable the resin production capacity to be doubled.
Around sixty engineers and technicians have been involved for almost two years in the research and completion phases of this internally-developed project said the company.
"This investment at Saint Fons will enable us to capture growth exactly where it is, while strengthening our market share in the other more mature sectors," said Pascal Chalvon Demersay, Bluestar Silicones chairman. "This capacity increase is exactly in line with our development strategy for global sales with new key accounts in markets where we already have a strong position."
This €7 million project represents the greatest investment made by Bluestar Silicones at the Saint Fons plant for over ten years.
"IRIS means we now have the best current technology for resin production at the Saint Fons plant," said Philippe Massuyes, plant manager for Silicones Rhône Alpes. "We are all the prouder given that it was designed by the teams in Saint Fons. After all the investment made at our plant in Roussillon at the beginning of the year, this is strong proof of Bluestar Silicones' will to develop its industrial plants in the Rhône region."
The opening of IRIS has been accompanied by the creation of a new processing center for discharges resulting from the resin production.
Bluestar Silicones is one of the world's leading manufacturers of silicones. With over 50 years' experience in silicones, Bluestar Silicones offers a complete range of silicone products in the fields of energy, electronics, aeronautics, automobile, construction, cosmetics, paramedics, moulding, paper and textile coatings and anti-foams. The company, a branch of China National Bluestar Corp, achieves a turnover of around €600 million euros and employs nearly 3,000 staff across the world.
Being a formulator is becoming much more difficult in light of increased regulatory pressures on common raw materials.
Formulators who develop coatings based on oxidatively cured (alkyd) binders face major regulatory obstacles for two key in…